SSB HOMES LIMITED

Company number 05588412 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: SSB HOMES LIMITED

1. Financial Health Score: B+

Explanation: SSB Homes Limited is a patient that has made a miraculous recovery from a near-terminal condition. Between 2015 and 2017, the business was technically insolvent, operating with negative net assets—a state akin to bleeding out financially. However, through what appears to be aggressive debt restructuring or a significant capital injection, the company has stabilized and is now building healthy equity. The B+ score reflects this excellent turnaround and current robust liquidity, held back only by a lingering "cholesterol" issue in the form of substantial long-term debts that still weigh on the balance sheet.

2. Key Vital Signs

  • Net Assets (The Patient's Constitution): £2,059,650 (2024). This is the core measure of financial health. After suffering negative equity (as low as -£1.1M in 2017), the company has steadily built a strong constitution, growing its net assets year-on-year for the last six consecutive years.
  • Current Ratio (Short-term Immunity): 3.38x (£3.79M Current Assets / £1.12M Current Liabilities). This is an exceptionally healthy pulse. It means the business has £3.38 in liquid assets for every £1 of short-term debts, indicating zero risk of immediate cash flow asphyxiation.
  • Long-term Liabilities (Arterial Plaque): £3,874,937. While down from £4.12M in 2023 and significantly down from its historical peak, this represents a heavy debt burden that requires ongoing management and interest payments.
  • Fixed Assets (Bone Density): £3,800,000. Consistent year-over-year, this indicates the company holds significant property assets (typical for the real estate and hotel sectors), providing a solid structural foundation.

3. Diagnosis

Symptom Analysis: Looking at the medical history of this company, the data reveals a classic case of over-leveraged expansion followed by a disciplined rehabilitation program. From 2015 to 2017, total liabilities vastly exceeded total assets. The business was kept alive on a financial ventilator, likely supported by director loans or patient creditors.

Around 2018/2019, a "surgical intervention" occurred—possibly a debt-for-equity swap, property refinancing, or an injection of capital from the parent company (Sav Group Ltd) and directors. Since that intervention, the patient has been in steady recovery.

Currently, the symptoms of distress have vanished. The reduction in both current creditors (down from £1.22M to £1.12M) and long-term creditors (down from £4.12M to £3.87M) shows that the business is actively paying down its debts rather than just servicing the interest. The slight drop in current assets (from £4.08M to £3.79M) is not a symptom of illness, but likely the natural result of using cash to cure its debt burden.

Prognosis: The outlook is highly stable. With only one employee, this is effectively a property asset-holding vehicle, likely generating rental or hospitality income. The "blood flow" (working capital) is robust, ensuring the company can comfortably meet its operational expenses and near-term obligations. As long as the underlying properties generate sufficient yield to service the remaining long-term debt, this patient will continue to strengthen its financial constitution.

4. Recommendations (Prescription for Optimal Health)

  • Continue the Debt Rehabilitation Program: The priority must remain the gradual reduction of the £3.87M in long-term creditors. Continuing to pay down this debt will lower interest expenses (the financial equivalent of lowering a fever) and increase net asset strength.
  • Cash Flow Stress Testing: With £3.79M in current assets, the company appears cash-rich, but we must ensure this isn't stagnant cash. In a high-interest-rate environment, ensuring this cash is working efficiently—either by offsetting debt or generating a safe yield—is essential.
  • Investigate the Provisions: There is a static £535,278 provision for liabilities on the balance sheet that hasn't changed between 2023 and 2024. Like a chronic low-grade inflammation, provisions need to be monitored to ensure they do not flare up into an actual cash outflow. Management should verify this estimate is still adequate or can be released to boost equity.
  • Asset Health Check: Because the company's health is heavily anchored in £3.8M of fixed assets (property), it is prudent to ensure these assets are regularly revalued and properly maintained to secure the income stream that services the debt.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 24 July 2026